Corundum Group, Inc. Eli Lilly & CO Transaction History

Corundum Group, Inc.

$254 Million
Q2 2024

A detailed history of Corundum Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Corundum Group, Inc. holds 3,929 shares of LLY stock, worth $3.48 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares

3,929

Previous 1,502 161.58%

Holding current value

$3.48 Million

Previous $1.17 Million 204.54%

% of portfolio

1.4%

Previous 0.56%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $1.76 Million - $2.21 Million	2,427 Added 161.58%	3,929 $3.56 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $37,900 - $50,705	-64 Reduced 4.09%	1,502 $1.17 Million
Q4 2023 Jan 23, 2024	BUY	$525.19 - $619.13 $4,201 - $4,953	8 Added 0.51%	1,566 $912,000
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $200,831 - $276,876	-462 Reduced 22.87%	1,558 $836,000
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $867,730 - $1.16 Million	-2,474 Reduced 55.05%	2,020 $947,000
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $720,661 - $846,382	2,320 Added 106.72%	4,494 $1.54 Million
Q4 2022 Jan 12, 2023	BUY	$321.55 - $374.67 $15,755 - $18,358	49 Added 2.31%	2,174 $795,000
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $26,090 - $29,732	88 Added 4.32%	2,125 $687,000
Q2 2022 Jul 25, 2022	BUY	$278.73 - $327.27 $16,445 - $19,308	59 Added 2.98%	2,037 $660,000
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $35,907 - $44,623	153 Added 8.38%	1,978 $566,000
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $17,988 - $22,323	80 Added 4.58%	1,825 $504,000
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $25,262 - $31,088	114 Added 6.99%	1,745 $403,000
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $27,263 - $35,264	-151 Reduced 8.47%	1,631 $374,000
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $2,629 - $3,403	16 Added 0.91%	1,782 $333,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $18,264 - $24,168	140 Added 8.61%	1,766 $298,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $237,753 - $275,005	1,626 New	1,626 $240,000
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $229,126 - $265,026	-1,567 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $213,770 - $257,270	1,567 New	1,567 $257,000
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $243,100 - $292,568	-1,782 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $212,147 - $262,577	1,782 New	1,782 $247,000
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $228,695 - $283,059	-1,921 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$106.92 - $132.43 $9,302 - $11,521	87 Added 4.74%	1,921 $252,000
Q3 2019 Nov 01, 2019	BUY	$106.79 - $116.16 $195,852 - $213,037	1,834 New	1,834 $205,000
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $196,066 - $213,269	-1,836 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$110.79 - $129.32 $1,551 - $1,810	14 Added 0.77%	1,836 $203,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $462,381 - $544,257	-4,154 Reduced 69.51%	1,822 $236,000
Q4 2018 Feb 19, 2019	BUY	$105.9 - $118.64 $632,858 - $708,992	5,976 New	5,976 $692,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.

Account

Corundum Group, Inc. Eli Lilly & CO Transaction History